Drug-labels.com

Ran-Fenofibrate S: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
100 mg, 160 mg
Active ingredient:
ATC code:
Similar drugs:

Source: Health Canada – Drug Product Database (DPD) and product monographs · About this document

Patient Medication Information: uses, side effects, how to take - Ran-Fenofibrate S

What is RAN-Fenofibrate S used for?

RAN-Fenofibrate S is used in adults, including adults with type 2 diabetes, to lower cholesterol and blood fat levels. RAN-Fenofibrate S is to be used together with dietary and lifestyle changes.

How does RAN-Fenofibrate S work?

RAN-Fenofibrate S lowers cholesterol by reducing the amount of bad cholesterol (LDL) and fatty substances in the blood (triglycerides). It also increases the amount of good cholesterol (HDL) in the blood.

What are the ingredients in RAN-Fenofibrate S?

Medicinal ingredient: fenofibrate

Non-medicinal ingredients: colloidal silicon dioxide, crospovidone, microcrystalline cellulose, povidone, pregelatinized starch, sodium lauryl sulfate, and sodium stearyl fumarate.

RAN- FENOFIBRATE S tablets 100 mg and 160 mg also contain lecithin, polyvinyly alcohol, talc, titanium dioxide and xanthan gum.

RAN-Fenofibrate S comes in the following dosage form:

Film-coated tablet: 100 mg and 160 mg

Do not use RAN-Fenofibrate S if you:

  • have serious liver or kidney problems;
  • have gallbladder problems;
  • have pancreatitis (an inflamed pancreas which causes abdominal pain);
  • are allergic (hypersensitive) to fenofibrate or similar drugs or if you are allergic to any of the ingredients in RAN-Fenofibrate S;
  • are allergic (hypersensitive) to peanuts, arachis oil, soya lecithin, lactose or related products due to risk of allergic reaction;

  • are pregnant, think you may be pregnant or are planning to get pregnant. If you get pregnant while taking RAN-Fenofibrate S, contact your healthcare professional immediately.

  • are breast-feeding or planning to breast-feed;
  • have a photoallergy (skin sensitivity to sunlight or UV light) when taking a fibrate (a class of drugs used for lowering cholesterol, which includes RAN-Fenofibrate S and gemfibrozol) or
  • an anti-inflammatory drug called ketoprofen;
  • are taking statins (another type of drug used to lower cholesterol) and have muscle problems or have potential risks of developing muscle problems;
  • are under 18 years of age.

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take RAN-Fenofibrate S. Talk about any health conditions or problems you may have, including if you:

  • have liver or kidney problems;
  • have pancreas problems;
  • have gallstones;
  • have thyroid problems;

Other warnings you should know about:

You should have regular check-ups with your healthcare professional while taking RAN-Fenofibrate S. Your healthcare professional will also do regular blood work to make sure you are responding well to RAN-Fenofibrate S and that you are not experiencing side effects. These side effects can include serious muscle problems, which can cause kidney damage or even death. The risk of muscle problems is higher in some patients. Tell your healthcare professional if you:

  • are over 70 years old;
  • have kidney or liver problems;
  • have thyroid problems;
  • or a close family member has muscle problems which run in the family;
  • drink large amounts of alcohol;
  • have a serious infection or have recently had surgery or suffered a trauma;
  • are dehydrated or suffer from excessive vomiting, diarrhea, or sweating;
  • are taking drugs called statins to lower cholesterol such as simvastatin, atorvastatin, pravastatin, rosuvastatin or fluvastatin;
  • have ever had muscle problems during treatment with fibrates such as fenofibrate, bezafibrate or gemfibrozil.
  • While taking RAN-Fenofibrate S if you experience muscle pain, tenderness or weakness, especially with a fever, contact your healthcare professional immediately.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with RAN-Fenofibrate S:

  • Statins (other drugs used to lower cholesterol) such as atorvastatin, pravastatin, simvastatin, etc. Taking a statin at the same time as RAN-Fenofibrate S may increase the risk of serious muscle problems.
  • Ezetimibe (used to lower cholesterol);
  • Blood thinners, such as warfarin;
  • Cyclosporine (a drug which may be taken following an organ transplant);
  • Cholestyramine or similar drugs (used to lower cholesterol);
  • Estrogens (hormones which may be found in birth control pills or hormone replacement therapy);
  • Some drugs used to treat diabetes, such as rosiglitazone or pioglitazone.

How to take RAN-Fenofibrate S:

  • RAN-Fenofibrate S should be taken with food.

  • Swallow the tablet whole with a glass of water.
  • Do not crush or chew the tablet.

Usual adult dose:

The recommended dose of RAN-Fenofibrate S is one 160 mg tablet daily.

Overdose:

If you think you have taken too much RAN-FENOFIBRATE S, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you forget a dose, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

What are possible side effects from using RAN-Fenofibrate S?

These are not all the possible side effects you may feel when taking RAN-Fenofibrate S. If you experience any side effects not listed here, contact your health care professional.

Side effects may include:

  • Stomach pain, constipation, diarrhea, gas
  • Nausea, vomiting
  • Headache
  • Dizziness
  • Fatigue
  • Trouble sleeping
  • Low sex drive
  • Skin rashes, redness and itching, sensitivity of the skin to light
  • Hair loss
  • Weight loss
  • Joint pain

RAN-Fenofibrate S can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

UNCOMMON

Allergic reaction: swelling of the face, lips, tongue or throat, which may cause difficulty in breathing

✓
Blood clot in the lung: sudden chest pain and trouble breathing✓
Blood clot in the leg: pain, redness or swelling in the legs✓

Inflammation of the

pancreas:

stomach pain that lasts and gets worse when you lie down,

✓

RARE

Serious muscle problems:

muscle pain or cramps, or muscle weakness, especially together with fever and

✓
Liver problems: yellowing of the skin and whites of the eyes, dark urine✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting(https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage

Store at 15°-30° C. Protect from moisture and light. Keep out of reach and sight of children.

If you want more information about RAN-FENOFIBRATE S:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) or by calling Ranbaxy Pharmaceuticals Canada Inc. at: 1-866-840-1340

RANBAXY

Ranbaxy Pharmaceuticals Canada Inc.

Brampton, ON L6T 1C1

Last revised: July 09, 2018

All trademarks are property of their respective owners.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02391309

Revision date stated in the text: July 9, 2018

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ran-Fenofibrate S

Rx or OTC
Prescription (Rx)?
DIN 02391309, 02391317
Schedule(s) PRESCRIPTION
Active ingredient(s) Fenofibrate
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AB Fibrates, lipid modifying drugs, plain
          1. C10AB05 Fenofibrate
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Approved
Current status date December 17, 2012
Strengths and forms
DIN Strength Dosage form(s) Current status
02391309 100 MG Tablet Approved December 17, 2012
02391317 160 MG Tablet Approved December 17, 2012

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.